Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
Become a Member | Sign in
Home>News>This Article

Free Stool DNA Extraction Kits with Each DiaSorin LIAISON® Ixt/Arrow™ Instrument

Published: Wednesday, January 15, 2014
Last Updated: Wednesday, January 15, 2014
Bookmark and Share
An ideal opportunity to experience how LIAISON® Ixt/Arrow™ magnetic bead technology overcomes the difficulties of extracting highly purified DNA from stool samples.

Building on the wide range of products available from DiaSorin for stool diagnostics, with each DiaSorin LIAISON® Ixt/Arrow™ instrument purchased during February 2014, DiaSorin is providing 2000€ worth of LIAISON® Ixt/Arrow™ Stool DNA extraction kits completely free of charge.  This offer provides an ideal opportunity to experience how LIAISON® Ixt/Arrow™ magnetic bead technology overcomes the difficulties of extracting highly purified DNA from stool samples.

Analysis of DNA from stool samples may be required to identify viral or bacterial pathogens shed in faeces.  In addition, analysis of genomic DNA in human stools is a new approach for the detection of colon cancer, designed to identify specific DNA markers in cells that are shed from the lining of the colon through the stool.  In addition to purifying viral and bacterial DNA, the LIAISON® Ixt/Arrow™ Stool DNA kits have also been validated for the extraction of human DNA from human stool samples1 and are used for detection of gastrointestinal disease such as Clostridium difficile, Helicobacter pylori, rotavirus and Enterohaemorrhagic Escherichia coli (EHEC).

The consistent extraction of purified DNA from stool samples is inherently difficult due to the complex and variable composition of faeces and the presence of high levels of PCR inhibitors in this matrix.  DiaSorin LIAISON® Ixt/Arrow™ Stool DNA extraction kits overcome this problem.  Utilising magnetic bead technology these kits rapidly and consistently yield high quality genomic, bacterial and viral DNA, ready for use in PCR and other downstream applications. 

Designed for use with the automated DiaSorin LIAISON® Ixt/Arrow™ instruments, the kits perform with high reproducibility1.  They have been shown to yield high quality DNA with very low occurrence of PCR inhibitory substances1.  By automating the purification and DNA extraction process, these kits reduce technician hands-on time and increase sample throughput.  They are fast and easy to set up, with all reagents required present in the prefilled cartridges, yielding highly purified DNA from up to 12 faecal samples at a time in less than 50 minutes.

LIAISON® Ixt/Arrow™ Stool DNA extraction kits form part of a wide range of products available from DiaSorin for the investigation of stool samples, including LIAISON® immunodiagnostic assays for Clostridium difficile, Helicobacter pylori, rotavirus and Enterohaemorrhagic Escherichia coli (EHEC).

In addition to Stool DNA, LIAISON® Ixt/Arrow™ nucleic acid extraction kits are available for a number of applications, such as: the extraction of RNA or DNA from a variety of sample matrices; the extraction of DNA from blood samples; BUGS’n BEADS for the extraction of nucleic acid from a wide range of pathogens; and cell separation.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Mathematical Model Forecasts the Path of Breast Cancer
Chances of survival depend on which organs breast cancer tumors colonize first.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Biomedical Imaging at One-Thousandth the Cost
Mathematical modeling enables $100 depth sensor to approximate the measurements of a $100,000 piece of lab equipment.
Improving Outcomes for Lung Cancer and Diabetic Patients
Novel technologies have been developed with support from SBRI Healthcare funding.
New Way of Detecting Cancer
A new RNA test of blood platelets can be used to detect, classify and pinpoint the location of cancer by analysing a sample equivalent to one drop of blood.
Rapid, Portable Ebola Diagnostic
Scientists confirmed the efficiency of the novel Ebola detection method in field trials.
New, Better Test for Prostate Cancer
A study from Karolinska Institutet shows that a new test for prostate cancer is better at detecting aggressive cancer than PSA.
Blood Test Picks Out Prostate Cancer Drug Resistance
Scientists have developed a blood test that can identify key mutations driving resistance to a widely used prostate cancer drug, and identify in advance patients who will not respond to treatment.
Antibody Targets Key Cancer Marker
University of Wisconsin-Madison researchers have created a molecular structure that attaches to a molecule on highly aggressive brain cancer and causes tumors to light up in a scanning machine.
Key Piece of MRSA Vaccine Puzzle
New research funded by the Health Research Board and the Wellcome Trust has pinpointed immune cells that could be targeted by an MRSA vaccine.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos